Improvement in symptom-related disruptions is associated with fewer days of short-acting beta-agonist use in asthma

被引：1
|
作者：
Kaye, Leanne [1 ]
Vy Vuong [1 ]
Barrett, Meredith A. [1 ]
Boers, Elroy [2 ]
Guilbert, Theresa [3 ,4 ]
机构：
[1] ResMed Sci Ctr, San Diego, CA 92123 USA
[2] ResMed Sci Ctr, Halifax, NS, Canada
[3] Univ Cincinnati, Dept Pediat, Cincinnati, OH USA
[4] Cincinnati Childrens Hosp Med Ctr, Pulm Div, Cincinnati, OH 45229 USA
来源：
NPJ PRIMARY CARE RESPIRATORY MEDICINE | 2022年 / 32卷 / 01期
关键词：
BURDEN;
D O I：
10.1038/s41533-022-00299-3
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
Significant indirect healthcare costs are related to uncontrolled asthma, including productivity loss. Days with short-acting beta-agonist (SABA) use is associated with symptom-related disruptions at work, home, and school. Digital self-management platforms may support fewer days with SABA medication use and may reduce symptom-related disruptions.
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Improvement in symptom-related disruptions is associated with fewer days of short-acting beta-agonist use in asthma
    Leanne Kaye
    Vy Vuong
    Meredith A. Barrett
    Elroy Boers
    Theresa Guilbert
    [J]. npj Primary Care Respiratory Medicine, 32
  • [2] Trends of short-acting beta-agonist (SABA) surrounding days of high use in asthma and COPD
    Hoch, Heather
    Gondalia, Rahul
    Anderson, William
    Barrett, Meredith
    Szefler, Stanley
    Van Sickle, David
    Stempel, David
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [3] Reducing short-acting beta-agonist overprescribing in asthma
    Ryan, Dermot
    [J]. BRITISH JOURNAL OF GENERAL PRACTICE, 2022, 72 (722): : 412 - 413
  • [4] Nighttime short-acting beta-agonist (SABA) in asthma and COPD
    Anderson, William
    Gondalia, Rahul
    Hoch, Heather
    Barrett, Meredith
    Szefler, Stanley
    Van Sickle, David
    Stempel, David
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [5] Prevalence and Weekly Patterns of High Short-Acting Beta-Agonist Use in Asthma and COPD
    Gondalia, R.
    Anderson, W. C.
    Hoch, H. E.
    Kaye, L.
    Szefler, S. J.
    Stempel, D. A.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [6] Higher short-acting beta-agonist use is associated with greater COPD burden
    Gondalia, Rahul
    Bender, Bruce G.
    Theye, Benjamin
    Stempel, David A.
    [J]. RESPIRATORY MEDICINE, 2019, 158 : 110 - 113
  • [7] IMPROVEMENT IN PRODUCTIVITY AND SHORT-ACTING BETA-AGONIST USE AMONG PATIENTS WITH ASTHMA USING A DIGITAL HEALTH PLATFORM
    Vuong, Vy
    Kaye, Leanne
    Boers, Elroy
    Barrett, Meredith A.
    [J]. ANNALS OF BEHAVIORAL MEDICINE, 2022, 56 (SUPP 1) : S310 - S310
  • [8] Effect of age on the conformity rate to short-acting beta-agonist use criteria in asthma
    Labrecque, M
    Laurier, C
    Champagne, F
    Kennedy, W
    Paré, M
    Cartier, A
    [J]. JOURNAL OF ASTHMA, 2003, 40 (07) : 829 - 835
  • [9] ASSOCIATION BETWEEN SHORT-ACTING BETA-AGONIST TYPE AND USE OF ASTHMA-RELATED EMERGENCY SERVICES.
    Korn, J. R.
    Lang, K. M.
    Nichols, C.
    Rajagopalan, K.
    Walsh, J.
    Menzin, J.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2011, 107 (05) : A38 - A39
  • [10] Improvement in Inhaled Short-acting Beta-agonist (SABA) Use by Education and Income Among Adults Enrolled in a Digital Asthma Program
    Kaye, L.
    Gondalia, R.
    Thompson, A.
    Henderson, K.
    Stempel, D. A.
    Barrett, M. A.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
12345